June 27 (Reuters) - Australia's Mayne Pharma Group Ltd
on Tuesday said it will acquire U.S. generic products
from Teva Pharmaceuticals for $652 million, helping it
propel into the top 2 in the general oral contraceptives market
in the United States.
Read more
No comments:
Post a Comment